Table 3. Characteristics of tumor type by patient cohort and by age.
Age: | <40 | 40–48 | 49–60 | >60 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||||||||
Cohort 1 | Cohort2 | Cohort 1 | Cohort2 | Cohort1 | Cohort 2 | Cohort 1 | ||||||||
Total (n) | 68 | 56 | 141 | 166 | 165 | 205 | 65 | |||||||
Median age at diagnosis (years) | 35.4 | 36 | 44 | 45.3 | 54 | 52.2 | 65.4 | |||||||
T stage | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) |
T1 | 30 | 45 | 34 | 61 | 75 | 53 | 114 | 69 | 89 | 54 | 153 | 75 | 38 | 59 |
T2 | 38 | 55 | 21 | 38 | 66 | 47 | 52 | 31 | 75 | 45 | 52 | 25 | 26 | 41 |
T3 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
Comparison | P = 0.015 | P = 0.006 | P = 0.001 | |||||||||||
Grade | ||||||||||||||
I | 5 | 7 | 8 | 14 | 24 | 17 | 34 | 20 | 29 | 18 | 62 | 30 | 21 | 32 |
II | 21 | 32 | 20 | 36 | 48 | 34 | 63 | 38 | 71 | 43 | 90 | 44 | 27 | 42 |
III | 41 | 59 | 28 | 50 | 68 | 49 | 69 | 42 | 61 | 37 | 53 | 26 | 17 | 26 |
Comparison | P = 0.321 | P = 0.775 | P = 0.009 | |||||||||||
Hormone receptor | ||||||||||||||
Positive | 38 | 57 | 36 | 64 | 100 | 71 | 132 | 80 | 123 | 75 | 174 | 85 | 52 | 80 |
Negative | 30 | 43 | 20 | 36 | 41 | 29 | 34 | 20 | 42 | 25 | 31 | 15 | 13 | 20 |
Comparison | P = 0.282 | P = 0.109 | P = 0.012 | |||||||||||
70-gene | ||||||||||||||
Good prognosis | 17 | 25 | 17 | 30 | 55 | 39 | 83 | 50 | 67 | 41 | 119 | 58 | 41 | 63 |
Poor prognosis | 51 | 75 | 39 | 70 | 86 | 61 | 83 | 50 | 98 | 59 | 86 | 42 | 24 | 37 |
Comparison | P = 0.506 | P = 0.054 | P = 0.012 |
Clinicopathologic characteristics of study patients by age group are shown for each cohort